CN110025394A - A kind of non-human primates cerebral apoplexy Model R & D method - Google Patents

A kind of non-human primates cerebral apoplexy Model R & D method Download PDF

Info

Publication number
CN110025394A
CN110025394A CN201810032244.6A CN201810032244A CN110025394A CN 110025394 A CN110025394 A CN 110025394A CN 201810032244 A CN201810032244 A CN 201810032244A CN 110025394 A CN110025394 A CN 110025394A
Authority
CN
China
Prior art keywords
animal
angiography
assessment
model
cerebral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810032244.6A
Other languages
Chinese (zh)
Inventor
杨立川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KUNMING BIOMED INTERNATIONAL
Original Assignee
KUNMING BIOMED INTERNATIONAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KUNMING BIOMED INTERNATIONAL filed Critical KUNMING BIOMED INTERNATIONAL
Priority to CN201810032244.6A priority Critical patent/CN110025394A/en
Publication of CN110025394A publication Critical patent/CN110025394A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D1/00Surgical instruments for veterinary use

Abstract

The present invention relates to clinical science studying technological domains, and disclose preparing experiment material: the compatible ventilator of syringe needle, 5F arterial cannula, 4F angiography catheter, 0.25mm angiography micro-wire, digital subtraction angiography (DSA) system, MRI system, nuclear magnetic resonance of 18gage, the compatible bio-signal acquisition system of nuclear magnetic resonance.The non-human primates cerebral apoplexy Model R & D method, stable machin cerebral ischemia re-pouring animal model is precisely prepared for by intravascular Coil embolization method, experimental animal infarct size is moderate and does not occur infarcted region hemorrhagic conversion after Reperfu- sion, animal energy long-term surviving, with corresponding neurologic impairment symptom and pass through the stability of the evaluation certificate of long-term iconography and behavior model, position and the degree of stroke can be accurately controlled using this method, and experimental animal is able to maintain stable clinical symptoms, therefore, this model is appropriate for safety and the efficiency assessment of cerebral apoplexy new treatment and novel drugs.

Description

A kind of non-human primates cerebral apoplexy Model R & D method
Technical field
The present invention relates to clinical science studying technological domains, specially a kind of non-human primates cerebral apoplexy Model R & D side Method.
Background technique
Cerebral apoplexy has become the common cause of the death of the world's second largest, caused by death and disabled to be that the whole world is brought heavy Financial burden, according to global stroke general pictures in 2014, analysis shows that, stroke incidence occupied first place in the world, and the death rate occupies the world the Two, there are about 3/4 apoplexy patient can there are the 60.3-80.5% that different degrees of sequelae, cerebral arterial thrombosis account for about stroke.
Non-human primate is due to anatomical structure, development and functionally similar to human nervous system's height, benefit Carry out Treatment of Stroke research with monkey stroke model, is to realize to answer from more mature rodent models to unknown Human clinical With a step essential in conversion, but still lack standard, widely accepted primate cerebral apoplexy model both at home and abroad at present, The generally existing experimental animal survival rate of the primate model reported both at home and abroad is low, and the animal of energy long-term surviving is often without phase The neurologic impairment symptom answered can not carry out subsequent assessment, this is because currently used modeling method such as thromboembolism Method, balloon embolization method, line brush, desmurgia, photochemical method etc. are poor to the controllability of infarct size, the excessive animal of infarct size Ischemic reaction weight, the death rate is high, and infarct size is small, though energy long-term surviving symptom is slight or does not have manifest symptom, or part is built Mould method differs larger with the pathophysiological change of disease itself, and current research due to animal survival rate it is low, almost do not have It is included in iconography and ethological long-term evaluation, especially ethological assessment.
Summary of the invention
(1) the technical issues of solving
In view of the deficiencies of the prior art, the present invention provides a kind of non-human primates cerebral apoplexy Model R & D methods, solve The problem of situation carry out long-term assessment can not be improved to function.
(2) technical solution
In order to achieve the above object, the present invention is achieved by the following technical programs: a kind of non-human primates cerebral apoplexy mould Type researches and develops method, comprising the following steps:
A1. preparing experiment material: syringe needle, 5F arterial cannula, 4F angiography catheter, the 0.25mm angiography of 18gage The compatible ventilator of micro-wire, digital subtraction angiography (DSA) system, MRI system, nuclear magnetic resonance, the compatible physiology of nuclear magnetic resonance Signal detection system.
A2. preparing experiment animal: five between twenty and fifty machins, male, the age 6-8 year old, weight 5-6kg, five old eat Crab monkey, male, age are greater than 10 years old, and weight is greater than 10kg.
A3. the preoperative health of preparing experiment animal and Baseline detection and inspection (baseline profiling check),
Test metabolizing parameters, hepatic and renal function, CBC.
The additional whole part serum sample of acquisition simultaneously saves, for the biomarker analysis in later period.
Neurology baseline estimate (Baseline neurological assessment).
A4. the method for building up of limitation cerebral ischemic model: machin similar in 6-9 years old weight of selection, experimental animal preserved skin Disinfection after Intravenous Anesthesia, takes a side position, and outer urethral catheterization gives electrocardio blood pressure monitoring, when necessary mask oxygen inhalation, using improvement Seldinger ' s method punctures right common femoral artery, is placed in 4F arterial sheath, is inserted into 4F conduit to right carotid, row right side through sheath Arteria carotis communis positive side position radiography is inserted into microtubular and seal wire to right side middle cerebral artery M 1 segment China and foreign countries 1/3 along 4F conduit later, makes Shadow confirms that position is accurately placed in 2 hours backed off after random spring rings of spring ring (2X6mm) Dense embolization afterwards and carries out in particular point in time Iconography, behaviouristics, blood biochemistry checking assessment.
A5. postoperative care
Operated cohort anus temperature is monitored after surgery, and 48 hours of blood pressure and heart rate, animal respiratory will maintain unobstructed shape State is waken up completely until animal.
Intervening equipment will take out after surgery, press point of puncture 30 minutes, then carry out pressure dressing with disinfection bandage.
Analgesic: injection terbutaline 0.01-0.03mg/ml.
Antibiotic: due to lasting exposed wound surgical procedure, in the preoperative with it is postoperative require according to the guidance of animal doctor into Row administration, medicament selection need to effectively antagonize the common pathogen that can cause wound infection, such as: cephalosporin, preoperative half Hour, postoperative 5-7 days, in this case: cefoperazone sodium 100mg/kg, bid.
Liquid supply: carrying out liquid supply to animal in the guidance of animal doctor, and animal recovery process needs to carry out in recovery room, IV conduit can retain during this period, be, if water shortage symptom occurs in animal, to need to give animal each vein drop for liquid supply 100ml salting liquid is infused, the animal injury degree shown according to MRI, dehydration therapy is to reduce intracranial pressure.
If the spasm of epilepsy pattern occurs in animal, animal antiepileptic is given.
Diet: animal will receive fluid replacement therapy, until restoring normal diet.
A6. postoperative follow-up
The assessment of neurology:
Before T2- imaging, postoperative in MCAO, every animal can all comment according to common non-human primate neurology Quantization table is assessed, can be there are two independent each self-appraisal of observer experienced in terms of neurological deficit assessment Point, this table focuses on motion function, and can also consider Behavioral change (state of mind) and vision and cranial nerve damage Wound, score is lower to represent bad function output.
A7.MRI is checked
Magnetic resonance angiography inspection can be in cerebral ischaemia the latter hour, latter two hour of Reperfu- sion and MCAO Restore and magnetic resonance disperse with the overturning of T2 attenuating liquid 24 hours after Reperfu- sion operation, is carried out after one hour of Reperfu- sion Amount imaging is to observe local ischemic damage and reperfusion injury, because embolism amount is measured by T2/Flair image, T2/ Flair image and histological evaluation have high correlation, and the assessment of infarct damage is based entirely on T2 image.
(3) beneficial effect
Compared with prior art, the present invention provides a kind of non-human primates cerebral apoplexy Model R & D method, have following The utility model has the advantages that
It is precisely prepared for stable machin cerebral ischemia re-pouring animal model by intravascular Coil embolization method, tests Animal infarct size is moderate and does not occur infarcted region hemorrhagic conversion after Reperfu- sion, animal energy long-term surviving, has corresponding neural function Can defective symptom and by the stability of the evaluation certificate of long-term iconography and behavior model, can accurately be controlled using this method The position of stroke processed and degree, and experimental animal is able to maintain stable clinical symptoms, therefore, this model is appropriate for brain soldier The safety of middle new treatment and novel drugs and efficiency assessment.
Detailed description of the invention
Fig. 1 is latter two hour schematic diagram of MCAO art of the present invention;
Fig. 2 is the postoperative one week schematic diagram of MCAO of the present invention.
Specific embodiment
Below in conjunction with the embodiment of the present invention, technical solution in the embodiment of the present invention is clearly and completely retouched It states, it is clear that described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.Based on the present invention In embodiment, every other implementation obtained by those of ordinary skill in the art without making creative efforts Example, shall fall within the protection scope of the present invention.
A kind of non-human primates cerebral apoplexy Model R & D method, comprising the following steps:
A1. preparing experiment material: syringe needle, 5F arterial cannula, 4F angiography catheter, the 0.25mm angiography of 18gage The compatible ventilator of micro-wire, digital subtraction angiography (DSA) system, MRI system, nuclear magnetic resonance, the compatible physiology of nuclear magnetic resonance Signal detection system.
A2. preparing experiment animal: five between twenty and fifty machins, male, the age 6-8 year old, weight 5-6kg, five old eat Crab monkey, male, age are greater than 10 years old, and weight is greater than 10kg.
A3. the preoperative health of preparing experiment animal and Baseline detection and inspection (baseline profiling check),
Test metabolizing parameters, hepatic and renal function, CBC.
The additional whole part serum sample of acquisition simultaneously saves, for the biomarker analysis in later period.
Neurology baseline estimate (Baseline neurological assessment).
A4. the method for building up of limitation cerebral ischemic model: machin similar in 6-9 years old weight of selection, experimental animal preserved skin Disinfection after Intravenous Anesthesia, takes a side position, and outer urethral catheterization gives electrocardio blood pressure monitoring, when necessary mask oxygen inhalation, using improvement Seldinger ' s method punctures right common femoral artery, is placed in 4F arterial sheath, is inserted into 4F conduit to right carotid, row right side through sheath Arteria carotis communis positive side position radiography is inserted into microtubular and seal wire to right side middle cerebral artery M 1 segment China and foreign countries 1/3 along 4F conduit later, makes Shadow confirms that position is accurately placed in 2 hours backed off after random spring rings of spring ring (2X6mm) Dense embolization afterwards and carries out in particular point in time Iconography, behaviouristics, blood biochemistry checking assessment.
A5. postoperative care
Operated cohort anus temperature is monitored after surgery, and 48 hours of blood pressure and heart rate, animal respiratory will maintain unobstructed shape State is waken up completely until animal.
Intervening equipment will take out after surgery, press point of puncture 30 minutes, then carry out pressure dressing with disinfection bandage.
Analgesic: injection terbutaline 0.01-0.03mg/ml.
Antibiotic: due to lasting exposed wound surgical procedure, in the preoperative with it is postoperative require according to the guidance of animal doctor into Row administration, medicament selection need to effectively antagonize the common pathogen that can cause wound infection, such as: cephalosporin, preoperative half Hour, postoperative 5-7 days, in this case: cefoperazone sodium 100mg/kg, bid.
Liquid supply: carrying out liquid supply to animal in the guidance of animal doctor, and animal recovery process needs to carry out in recovery room, IV conduit can retain during this period, be, if water shortage symptom occurs in animal, to need to give animal each vein drop for liquid supply 100ml salting liquid is infused, the animal injury degree shown according to MRI, dehydration therapy is to reduce intracranial pressure.
If the spasm of epilepsy pattern occurs in animal, animal antiepileptic is given.
Diet: animal will receive fluid replacement therapy, until restoring normal diet.
A6. postoperative follow-up
The assessment of neurology:
Before T2- imaging, postoperative in MCAO, every animal can all comment according to common non-human primate neurology Quantization table is assessed.It can be there are two independent each self-appraisal of observer experienced in terms of neurological deficit assessment Point, this table focuses on motion function, and can also consider Behavioral change (state of mind) and vision and cranial nerve damage Wound, score is lower to represent bad function output.
A7.MRI is checked
Magnetic resonance angiography inspection can be in cerebral ischaemia the latter hour, latter two hour of Reperfu- sion and MCAO Restore and magnetic resonance disperse with the overturning of T2 attenuating liquid 24 hours after Reperfu- sion operation, is carried out after one hour of Reperfu- sion Amount imaging is to observe local ischemic damage and reperfusion injury, because embolism amount is measured by T2/Flair image, T2/ Flair image and histological evaluation have high correlation, and the assessment of infarct damage is based entirely on T2 image.
The beneficial effects of the present invention are: being precisely prepared for stable machin cerebral ischemia by intravascular Coil embolization method Reperfu- sion animal model, experimental animal infarct size is moderate and does not occur infarcted region hemorrhagic conversion after Reperfu- sion, and animal can be long-term Survival, has corresponding neurologic impairment symptom and by the stability of the evaluation certificate of long-term iconography and behavior model, Position and the degree of stroke can be accurately controlled using this method, and experimental animal is able to maintain stable clinical symptoms, because This, this model is appropriate for safety and the efficiency assessment of cerebral apoplexy new treatment and novel drugs.
It although an embodiment of the present invention has been shown and described, for the ordinary skill in the art, can be with A variety of variations, modification, replacement can be carried out to these embodiments without departing from the principles and spirit of the present invention by understanding And modification, the scope of the present invention is defined by the appended.

Claims (1)

1. a kind of non-human primates cerebral apoplexy Model R & D method, which comprises the following steps:
A1. preparing experiment material: the syringe needle of 18gage, 5F arterial cannula, 4F angiography catheter, 0.25mm angiography is micro- leads Silk, the compatible ventilator of digital subtraction angiography (DSA) system, MRI system, nuclear magnetic resonance, the compatible physiological signal of nuclear magnetic resonance Detection system;
A2. preparing experiment animal: five between twenty and fifty machins, male, the age 6-8 year old, weight 5-6kg, five old age machins, Male, age are greater than 10 years old, and weight is greater than 10kg;
A3. the preoperative health of preparing experiment animal and Baseline detection and inspection (baseline profiling check),
Test metabolizing parameters, hepatic and renal function, CBC;
The additional whole part serum sample of acquisition simultaneously saves, for the biomarker analysis in later period;
Neurology baseline estimate (Baseline neurological assessment);
A4. the method for building up of limitation cerebral ischemic model: machin similar in 6-9 year old weight of selection, experimental animal preserved skin sterilize, After Intravenous Anesthesia, a side position is taken, outer urethral catheterization gives electrocardio blood pressure monitoring, when necessary mask oxygen inhalation, using improvement Seldinger ' s method punctures right common femoral artery, is placed in 4F arterial sheath, is inserted into 4F conduit to right carotid, row right side through sheath Arteria carotis communis positive side position radiography is inserted into microtubular and seal wire to right side middle cerebral artery M 1 segment China and foreign countries 1/3 along 4F conduit later, makes Shadow confirms that position is accurately placed in 2 hours backed off after random spring rings of spring ring (2X6mm) Dense embolization afterwards and carries out in particular point in time Iconography, behaviouristics, blood biochemistry checking assessment;
A5. postoperative care
Operated cohort anus temperature is monitored after surgery, and 48 hours of blood pressure and heart rate, the state that animal respiratory will remain unobstructed is straight It wakes up completely to animal;
Intervening equipment will take out after surgery, press point of puncture 30 minutes, then carry out pressure dressing with disinfection bandage;
Analgesic: injection terbutaline 0.01-0.03mg/ml;
Antibiotic: due to lasting exposed wound surgical procedure, in the preoperative with it is postoperative require to be carried out according to the guidance of animal doctor to Medicine, medicament selection need to effectively antagonize the common pathogen that can cause wound infection, such as: cephalosporin, preoperative half an hour, Postoperative 5-7 days, in this case: cefoperazone sodium 100mg/kg, bid;
Liquid supply: liquid supply is carried out to animal in the guidance of animal doctor, animal recovery process needs to carry out in recovery room, herein Period IV conduit can retain, and be, if water shortage symptom occurs in animal, to need to give animal each intravenous drip for liquid supply 100ml salting liquid, the animal injury degree shown according to MRI, dehydration therapy is to reduce intracranial pressure;
If the spasm of epilepsy pattern occurs in animal, animal antiepileptic is given;
Diet: animal will receive fluid replacement therapy, until restoring normal diet;
A6. postoperative follow-up
The assessment of neurology:
Before T2- imaging, postoperative in MCAO, every animal all can be according to common non-human primate neurological score amount Change table to be assessed, can respectively score there are two independent observer experienced in terms of neurological deficit assessment, this A table focuses on motion function, and can also consider Behavioral change (state of mind) and vision and cranial nerve damage, obtains Divide the lower function output for representing bad luck;
A7.MRI is checked
Magnetic resonance angiography inspection can in cerebral ischaemia the latter hour, latter two hour of Reperfu- sion and MCAO and again 24 hours after perfusion operation, T2 attenuating liquid overturning recovery and diffusion tensor imaging are carried out after one hour of Reperfu- sion Local ischemic damage and reperfusion injury are observed, because embolism amount is measured by T2/Flair image, T2/Flair Image and histological evaluation have high correlation, and the assessment of infarct damage is based entirely on T2 image.
CN201810032244.6A 2018-01-12 2018-01-12 A kind of non-human primates cerebral apoplexy Model R & D method Pending CN110025394A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810032244.6A CN110025394A (en) 2018-01-12 2018-01-12 A kind of non-human primates cerebral apoplexy Model R & D method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810032244.6A CN110025394A (en) 2018-01-12 2018-01-12 A kind of non-human primates cerebral apoplexy Model R & D method

Publications (1)

Publication Number Publication Date
CN110025394A true CN110025394A (en) 2019-07-19

Family

ID=67234505

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810032244.6A Pending CN110025394A (en) 2018-01-12 2018-01-12 A kind of non-human primates cerebral apoplexy Model R & D method

Country Status (1)

Country Link
CN (1) CN110025394A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110569968A (en) * 2019-10-18 2019-12-13 上海大学 Method and system for evaluating entrepreneurship failure resilience based on electrophysiological signals
CN116525121A (en) * 2023-07-05 2023-08-01 昆明同心医联科技有限公司 Method for establishing primary spring coil recommendation model of embolic aneurysm and application of primary spring coil recommendation model

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110569968A (en) * 2019-10-18 2019-12-13 上海大学 Method and system for evaluating entrepreneurship failure resilience based on electrophysiological signals
CN116525121A (en) * 2023-07-05 2023-08-01 昆明同心医联科技有限公司 Method for establishing primary spring coil recommendation model of embolic aneurysm and application of primary spring coil recommendation model
CN116525121B (en) * 2023-07-05 2023-09-26 昆明同心医联科技有限公司 Method for establishing primary spring coil recommendation model of embolic aneurysm and application of primary spring coil recommendation model

Similar Documents

Publication Publication Date Title
Jansen et al. Continuous variability of fetal PO2 in the chronically catheterized fetal sheep
Wijdicks Brain death guidelines explained
Pudenz Experimental and clinical observations on the shunting of cerebrospinal fluid into the circulatory system
CN110025394A (en) A kind of non-human primates cerebral apoplexy Model R & D method
Landt et al. Cardiodynamic and electrocardiographic changes in normal pregnancy
Kimura et al. The isoelectric electroencephalogram: Significance in establishing death in patients maintained on mechanical respirators
Kleinhaus et al. Effects of laparoscopy on mesenteric blood flow
Mathew et al. Atrial fibrillation associated with seizure in a case of frontal meningioma
Schorstein Fatal intracranial venous haematoma following ventricular drainage
Hicks et al. The vestibulo-ocular (caloric) reflex in the diagnosis of cerebral death
Jan Brain death criteria. The neurological determination of death
MARTIN et al. Influence of emotional and physical stimuli on pressure in the isolated vein segment
Joffe Brain death is not death: a critique of the concept, criterion, and tests of brain death
CN101986834A (en) Method for preparing rhesus focal cerebral ischemia model
CN207838011U (en) Double horizontal balloon occlusions pressurization infusion systems in aorta lumen
CN112971707A (en) Multifunctional medical infusion related exudation, heart rate and body temperature monitor and system
Cekmen et al. A memantin HCL intoxication responsive to plasmapheresis therapy
CN211609747U (en) Multifunctional medical infusion related exudation, heart rate and body temperature detector and system
Filler et al. Muscle pH, pO2, pCO2 monitoring: A review of laboratory and clinical evaluations
Karcıoğlu How to consider and manage brain death in an emergency setting
Demarin et al. Consensus opinion on diagnosing brain death-Guidelines for use of confirmatory tests
CN213852531U (en) Puncture positioning device for anesthesia
Notkin et al. CLINICAL AND EXPERIMENTAL OBSERVATIONS ON THE BABINSKI REVERSAL, CARDIOVASCULAR REACTIONS, RESPIRATORY AND PUPILLARY CHANGES DURING THE CONVULSIVE AND POSTCONVULSIVE STAGES OF GENERAL AND EXPERIMENTAL EPILEPSY
Bolduc et al. Brain death and ethical issues: Death by neurological criteria
ROSENTHAL Changes in angioscotomas associated with the administration of sulfanilamide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190719

RJ01 Rejection of invention patent application after publication